Recalls & Warnings May 08, 2024 APG SEVEN Warned for Promoting Products for Cancer, Depression, Arthritis, & More On April 18, 2024, the FDA issued a Warning Letter to APG SEVEN, INC following a review of the companys product labels, website, and social media, which found statements about the companys BioMoringa, BioDiabetin, Maca Plus, BioProstate, Immune Support, HongoTrap, Honbacterol,
Working solutions at room temperature should be used within 24 hours
PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations
Tumour-initiating cells: challenges and opportunities for anticancer drug discovery
They are also believed to have a role in improving the energy level and immune system function, although strong clinical evidence supporting these effects remains limited